FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35641711000001106: Bictegravir + Emtricitabine + Tenofovir alafenamide (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Aug 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109422301000001116 Bictegravir + Emtricitabine + Tenofovir alafenamide (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109422401000001112 Bictegravir + Emtricitabine + Tenofovir alafenamide en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bictegravir + Emtricitabine + Tenofovir alafenamide Is a Product containing integrase strand transfer inhibitor true Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Is a Product containing emtricitabine false Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Is a Product containing tenofovir true Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Is a Virtual therapeutic moiety true Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Has active ingredient Tenofovir true Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Has active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Bictegravir + Emtricitabine + Tenofovir alafenamide Has active ingredient Substance with integrase strand transfer inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Is a True Bictegravir + Emtricitabine + Tenofovir alafenamide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start